Nasdaq · Healthcare
P3 Health Partners Inc. (PIII)
As-reported financials and recent SEC filings for P3 Health Partners Inc., latest fiscal period FY2024. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.46B
Net income
$-147.9M
Net margin
-10.1%
Diluted EPS
$-45.26
ROE
95.3%
P/E (TTM)
—
Market cap
$2.30B
Debt / equity
-1.5×
Income statement (as reported)
| Line | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.46B | $1.50B | $1.27B | $1.05B | $578.6M |
| Gross profit | — | — | — | — | — |
| Operating income | $-270.3M | $-320.7M | $-167.9M | $-1.56B | $-129.1M |
| Net income | $-147.9M | $-135.8M | $-57.8M | $-270.1M | $-146.4M |
| Diluted EPS | $-45.26 | $-54.06 | $-63.00 | $-92.86 | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-12
View on EDGAR →8-K2026-06-10
View on EDGAR →8-K2026-05-26
View on EDGAR →42026-05-18
View on EDGAR →8-K2026-05-15
View on EDGAR →10-Q2026-05-14
View on EDGAR →8-K2026-05-14
View on EDGAR →DEFA14A2026-04-30
View on EDGAR →Go deeper on PIII
Search P3 Health Partners Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.